Who Owns West Pharmaceutical Services Stock?
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 101.95%
- Institutions (% of float)
- 102.62%
- Held by insiders
- 0.66%
- Institutional holders
- 1,216
- Institutions 99.3%
- Insiders 0.7%
- Public and other 0.0%
Who owns West Pharmaceutical Services stock?
Institutional investors own about 101.9% of West Pharmaceutical Services's shares, spread across 1,216 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.66% of WST.
The largest institutional holders are Blackrock Inc. (9.45%), Vanguard Capital Management LLC (6.56%) and Vanguard Portfolio Management LLC (5.71%). Together, the top 10 institutions control 46.0% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their WST positions and 8 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of WST
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 6.65M | 9.45% | -2.7% |
| Vanguard Capital Management LLC | 4.61M | 6.56% | -1.5% |
| Vanguard Portfolio Management LLC | 4.02M | 5.71% | -1.9% |
| FMR, LLC | 3.57M | 5.08% | +186.0% |
| State Street Corporation | 3.35M | 4.76% | +1.7% |
| Artisan Partners Limited Partnership | 2.41M | 3.43% | -9.3% |
| Bank Of New York Mellon Corporation | 2.04M | 2.90% | -17.1% |
| Generation Investment Management LLP | 2.03M | 2.88% | -9.6% |
| Geode Capital Management, LLC | 1.90M | 2.70% | -0.5% |
| T. Rowe Price Investment Management, Inc. | 1.81M | 2.56% | -22.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of WST
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.24M | 3.19% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 1.83M | 2.60% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 1.53M | 2.18% |
| Fidelity Contrafund | 1.12M | 1.59% |
| iShares Trust-iShares Core S&P 500 ETF | 940.74K | 1.34% |
| VANGUARD INDEX FUNDS-Vanguard Growth Index Fund | 940.52K | 1.34% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 917.08K | 1.30% |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 894.78K | 1.27% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 875.03K | 1.24% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 865.33K | 1.23% |
Frequently asked questions
Who is the largest shareholder of West Pharmaceutical Services?
Blackrock Inc. is the largest institutional shareholder of WST, owning 9.45% of shares outstanding (6.65M shares) as of its latest 13F filing.
What percentage of West Pharmaceutical Services is owned by institutions?
Institutions own about 101.9% of WST shares and 102.6% of the public float.
How much of West Pharmaceutical Services do insiders own?
Insiders, such as officers and directors, own about 0.66% of WST shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.